Role of PLVAP in Regulation of Aqueous Outflow Facility
The research of Drs. Overby and Tamm focuses on the mechanisms of pressure regulation in the eye, with the goal to understand why pressure becomes elevated in glaucoma and what can be done to more successfully lower pressure to preserve vision in glaucoma patients. They focus their research on a single layer of cells that create a porous barrier to fluid drainage from the eye. This barrier— known as Schlemm’s canal endothelium—becomes altered in glaucoma, having fewer pores that they believe impedes fluid drainage and elevates pressure. Furthermore, their research has established that Schlemm’s canal cells cultured from glaucoma eyes have impaired pore-forming ability.
Drs. Overby and Tamm hypothesize that pore formation is a target for glaucoma therapy, such that if they can rescue normal pore formation in Schlemm’s canal cells from glaucoma eyes, they could enhance drainage and more successfully lower pressure. To do this, however, they must first understand the pore forming machinery in Schlemm’s canal cells, and they have taken a hint from other pore-forming cells elsewhere in the eye, kidney and liver. These other cells form pores (albeit pores that are much smaller than those in Schlemm’s canal) through a protein known as plasmalemmal vesicle-associated protein (PLVAP), and they hypothesize that PLVAP is also important for pore formation in Schlemm’s canal cells. Therefore, Drs. Overby and Tamm are investigating how alterations in PLVAP protein expression affects pressure regulation and barrier function in isolated Schlemm’s canal cells and in donated eyes.
First published on: Monday, July 1, 2013
Last modified on: Thursday, June 20, 2013